View Older Stories View More Recent Stories

Feb 10, 2021 09:05AM ConcertoHealth and Perfect Health Are Now ConcertoCare
Feb 10, 2021 07:02AM Sema4 to Combine with SPAC, CM Life Sciences (CMLF)
Feb 10, 2021 07:00AM  Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth
Feb 8, 2021 08:00AM Dana-Farber Cancer Institute and Deerfield Management Launch Riverway Discoveries
Feb 3, 2021 09:35AM Pairwise Raises $90 Million to Bring New Varieties of Fruits and Vegetables to Market
Feb 3, 2021 08:00AM SpectraWAVE Announces $13.2 Million Series A-2 Financing from Existing Investors to Bring Intracoronary Imaging Technology to Market
Jan 27, 2021 08:00AM Encodia Closes $75M Series C Financing Led by Northpond Ventures and Deerfield Management
Jan 27, 2021 06:00AM Nuvalent Launches with $50M Series A Financing from Deerfield Management to Develop Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
Jan 22, 2021 09:03AM COVID Test Results in 15min with New At-Home Test Service from Ready
Jan 21, 2021 12:00AM MIVI Neuroscience Secures Series B Funding
Jan 19, 2021 07:00AM Terns Announces FDA Clearance of Investigational New Drug (IND) Application for First-in-Human Phase 1 Trial of TERN-501, its THR-Beta Agonist in Development for the Treatment of NASH
Jan 15, 2021 11:45AM Valneva Announces Amendment to Deerfield and OrbiMed Debt Facility Terms
Jan 15, 2021 11:45AM Valneva Announces Amendment to Deerfield and OrbiMed Debt Facility Terms
Jan 12, 2021 07:00AM Terns Completes Enrollment in Phase 2a Clinical Trial of TERN-101 in NASH Patients
Jan 11, 2021 08:30AM Avidity Biosciences Announces Changes to its Board of Directors
Jan 11, 2021 07:00AM Blade Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Jan 7, 2021 11:45AM Valneva Reports FY 2020 Cash of Over €200 Million
Jan 7, 2021 11:45AM Valneva Reports FY 2020 Cash of Over €200 Million
Jan 7, 2021 07:00AM Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
Jan 5, 2021 04:35PM Terns Appoints Three New Independent Directors to its Board
Jan 5, 2021 07:00AM Terns Closes $87 Million Series C Financing to Advance NASH Portfolio
Dec 30, 2020 04:23PM Form 13F-HR/A DEERFIELD MANAGEMENT For: Sep 30
Dec 22, 2020 08:00AM Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs
Dec 22, 2020 08:00AM  Deerfield Launches a Novel Funding Mechanism, the X-Seed Award, to Support Early-Stage Life Sciences and Underrepresented Company Founders
Dec 22, 2020 08:00AM  Deerfield Launches a Novel Funding Mechanism, the X-Seed Award, to Support Early-Stage Life Sciences and Underrepresented Company Founders
Dec 21, 2020 05:20PM Form SC 13D/A Deerfield Healthcare Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Dec 18, 2020 11:35AM Deerfield Healthcare Technology Acquisitions (DFHT) Announces Proposed Business Combination to Form CareMax
Dec 18, 2020 11:30AM Deerfield Healthcare Technology Acquisitions Corp. Announces Proposed Business Combination to Form CareMax
Dec 18, 2020 09:00AM Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference
Dec 18, 2020 09:00AM Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference
Dec 17, 2020 10:00AM Octave Bioscience Secures $32 Million Series B Financing
Dec 17, 2020 08:00AM Global Genes, Leaders in Life Sciences and Pharma, and Informa’s Biotech Showcase™ Partner to Connect Rare Disease Advocates, Investors and Companies at RARE Beyond the Square
Dec 10, 2020 08:10AM Aytu BioScience (AYTU) Announces Merger Agreement with Neos Therapeutics
Dec 10, 2020 08:00AM Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company
Dec 10, 2020 06:01AM Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical Company
Dec 9, 2020 08:00AM Deerfield Announces 2021 Cure Diversity, Innovation and Management Initiatives
Dec 8, 2020 04:00PM Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program
Dec 8, 2020 08:00AM Vatica Health Appoints Experienced Executive Shannon Delage to its Board of Directors
Nov 23, 2020 07:43PM Lumos Pharma to Participate in December Investor Conferences
Nov 23, 2020 07:42PM Lumos Pharma to Participate in December Investor Conferences
Nov 19, 2020 08:30AM Syngene and Deerfield Discovery and Development (3DC) sign 5-year strategic collaboration
Nov 16, 2020 04:19PM Form 13F-HR DEERFIELD MANAGEMENT For: Sep 30
Nov 16, 2020 07:30AM Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results
Nov 12, 2020 09:00AM Springtide Announces $18.1M in Funding to Accelerate Centers for Autism Care
Nov 12, 2020 08:00AM Bridge Medicines Announces Additional Funding of $10 Million from Inside Investors
Nov 10, 2020 04:01PM Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
Nov 10, 2020 04:01PM Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
Nov 10, 2020 08:00AM Boston Children’s Hospital and Deerfield Join Forces to Accelerate the Development of Novel Therapies to Patients
Nov 9, 2020 07:00AM Blade Therapeutics to Present at the 2020 Stifel Virtual Healthcare Conference
Oct 29, 2020 09:00AM Lumos Pharma to Participate in November Investor Conferences
View More Recent Stories View Older Stories